Company Filing History:
Years Active: 2021-2023
Title: Daniel S. Quintana: Innovator in Social Cognition Modulation
Introduction
Daniel S. Quintana is an impressive inventor based in Oslo, Norway. With a focus on advancing social cognition and behavior modulation, he has contributed significantly to the field of medical innovations. He holds two patents, each showcasing his dedication to improving human interaction and emotional well-being through innovative delivery methods.
Latest Patents
Among Daniel's latest patents is a device designed for intranasal administration, entitled “A delivery device for and method of modulating a condition relating to social cognition and/or behaviour in a human subject using oxytocin, non-peptide agonists thereof and/or antagonists thereof.” This invention includes a carefully structured nosepiece to facilitate the delivery of less than 24 IU of oxytocin through the nasal cavity to the upper region posterior of the nasal valve, targeting areas innervated by the trigeminal nerve. This innovative approach aims to enhance the efficacy of treatments designed to impact social behavior positively.
Career Highlights
Daniel has worked with notable companies such as Optinose AS and Optinose Inc., contributing his expertise to high-impact projects. His work in these organizations underlines his commitment to leveraging innovation in medical delivery systems, particularly related to cognitive modulation.
Collaborations
Collaboration plays a crucial role in Daniel's journey as an inventor. He has worked alongside esteemed colleagues, including Per Gisle Djupesland and Ramy A. Mahmoud. Their collective expertise has reinforced his innovative projects, further enriching the scope of their research and the impact of their inventions.
Conclusion
Daniel S. Quintana exemplifies the spirit of innovation with his commitment to enhancing human cognition and behavior. His patents represent a significant advancement in the delivery of therapeutic agents, which could lead to transformative changes in how social cognition conditions are treated. As he continues to collaborate and push the boundaries of invention, the future holds exciting possibilities for his contributions to the medical field.